Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV

Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development

704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates: Molecular Therapy - Nucleic Acids

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations - Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano

Vaccines, Free Full-Text

Frontiers Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination

Immunogenicity of a DNA vaccine candidate for COVID-19

A brief review on DNA vaccines in the era of COVID-19